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The  recognition  of  two  distinct  pathways  for  differentiation  of  antigen- 
reactive T  and B  cells and the separate role that each of these cell types plays 
in  cellular  and  humoral  immune  responses  has  greatly  enhanced  our  under- 
standing of the immune system.  It is now well established  that T  cells have a 
critical  role  in  the  regulation  of  B-cell  responses  to  antigen  and  may  either 
enhance  or  suppress  antibody  responses  depending  on  the  experimental  cir- 
cumstances  (1).  In  contrast,  the  required  interactions  among  different  cell 
types and  the  regulatory  mechanisms  involved in  expression  of cell-mediated 
immune  responses  have  been  less  clearly  defined.  In one  category of cellular 
immune  responses,  when  the  sensitizing  antigen  is  a  structural  component of 
cell membranes, some T  cells develop into cytotoxic lymphocytes (CL)' capable 
of destroying cells bearing that antigen. Thus, a manifestation of cell-mediated 
immune  responses  such  as  allograft  responses  (2),  graft-vs.-host  (GVH)  reac- 
tions  (3),  and immune rejection of tumor cells is the destruction of target cells 
bearing  antigens  to  which  T  lymphocytes  have  been  sensitized  (4).  Data 
relating  to  cell  interactions  and  regulatory  mechanisms  in  these  responses 
have  been  accumulating  recently.  Evidence  for  a  lack  of  involvement  of  B 
lymphocytes in the generation of cytotoxic T  lymphocytes has been obtained 
(5,  6).  Most  conclusive  was  the  demonstration  by  Wagner  et  al.  (7),  that 
nearly pure populations  of T  cells,  such  as thymus cells or cortisone-resistant 
thymocytes, are  able  to  generate  strong  CL responses  in vitro.  These  studies 
are in complete agreement with the in vivo findings of Cerottini  et al.  (8)  and 
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demonstrate  that  the  generation  of  CL  occurs  independently and  without 
critical  influence of  B  cells.  Furthermore,  a  concept  that  functional hetero- 
geneity  exists  and  collaboration occurs  among  T-cell  populations has  been 
developing. Asofsky et al.  (3,  9)  have shown that in GVH responses coopera- 
tive cell interactions take place in which amplifier T  cells augment the activity 
of the precursors of CL which inflict immunologic injury and target cell dam- 
age. 
Rich  and  Pierce  (10)  reported  that  concanavalin A  (Con  A)-activated 
lymphoid cells  suppress  in Vitro primary and  secondary plaque-forming cell 
(PFC)  responses  by  mouse  spleen  cells  to  heterologous  erythrocytes.  This 
lymphocyte  population  was  thymus  derived,  resistant  to  irradiation,  and 
characteristically similar to  antigen-activated helper T  cells. The present ex- 
periments were undertaken to determine if mitogen-activated T  cells can also 
exert  regulatory influences on  the  generation of  cytotoxic T  lymphocytes in 
vitro.  The data  clearly indicate that  Con A-activated lymphocytes can sup- 
press the development of  CL  generated in one-way mixed leukocyte cultures 
(MLC). 
Materials  and Methods 
Miee.--Female C57BL/6  (H-2b),  Balb/c (H-2d), and DBA/2  (H-2  d) mice, 2- to 4-mo of 
age  (Jackson Laboratories, Bar Harbor,  Maine), were maintained  on acidified-chlorinated 
water and laboratory chow ad libitum. 
Con  A.--Twice recrystallized Con A  (Nutritional  Biochemicals Corporation, Cleveland, 
Ohio) was prepared for addition to cultures as described previously (11). 
Cell Culture  System.--Preparafion of spleen cell suspensions and techniques of cell culture 
have been previously described in detail (11). One-way MLC were employed to generate CL 
activated  toward H-2  b or H-2  d alloanfigens (12). Cultures containing 25  X  106 responding 
spleen cells and an equal number of mltomycin C-treated allogeneic spleen cells were incu- 
bated  in 5 ml of a completely supplemented Eagle's minimal essential medium containing 
10v'/v fetal bovine serum (lot E21806, Reheis Chemical Company, Kankakee, Ill.), in 60-ram 
plastic Petri dishes (no. 3002, Falcon Plastics, Div. of BioQuest, Oxnard, Calif.) under modi- 
fied Mishell-Dutton conditions (11) for the desired period of time. 
Mitomycin C Treatment.--Spleen cells (100 X 106 cells/m]) were treated with mitomycin C 
(Sigma Chemical Co., St. Louis, Mo.) at a final concentration of 50/zg/ml for 30 min at 37°C. 
Cells were washed twice in Hanks' balanced salt solution lacking sodium bicarbonate (HBSS) 
and resuspended in culture medium at the desired density for addition to the MLC. 
Tumor Cell Lines.--Tumors were maintained in ascitic form by serial transfer in syngeneic 
mice. P815 mastocytoma (//-2  d) and EL4 leukemia (H-2  b) cells were generously provided by 
Dr. Eric Martz of our department. 
After harvest  from the peritoneal cavity,  10-15 X  108 cells in 1-ml HBSS were mixed 
with 0.15 ml 51Cr as Na2CrO4 (1  mCi/ml, ~---  5/zg Cr/ml, Radiochemlcal Centre, Amersham, 
England) in isotonic saline. Mter 30-min incubation at 37°C, target tumor cells were washed 
three times in HBSS and resnspended in culture medium at 5 X  105 cells/ml for use in the 
alCr-release assay. 
51Cr-Release Assay.--Cells from triplicate MLC were harvested, pooled, and washed twice 
in HBSS. Cell number and viability by trypan blue exclusion were determined using a  Cyto- 
graf 6300 A  (Bio/Physics  Systems Inc., Mahopac, N.Y.).  Cytotoxic lymphocyte  activity 358  SUPPRESSION  OF  ALLOGRAFT  RESPONSES  IN  VITRO 
generated in vitro was quantitatively fitrated by the ~lCr-release method of Cerottini et  al. 
(8), modified as follows: Lymphocytes were adjusted to  10 X  106 viable cells/ml and  serial 
twofold dilutions were prepared in culture medium. 0.1 ml of the respective cell dilutions and 
0.1 ml of the SlCr-labeled target cells (5 X  105 cells/ml) were mixed in 10 X  75 mm glass  test 
tubes in triplicate. The resulting viable spleen cell to tumor cell ratios were 20, 10, 5, 2.5, and 
1.25. 0.5 ml of medium was added and the reaction mixtures were incubated without rooking 
at 37°C in a humidified atmosphere of 5% carbon dioxide and 95% air for 6 h. After centrifu- 
gation, radioactivity in the supernatant fluid was measured in a  Packard autogamma  scin- 
tillation counter (Packard Instrument Co., Inc., Downers Grove, Ill.). Results are  expressed 
as the percent of 51Cr released as determined by the following formula: 
%51Cr release  = 
100 X  ([S1Cr  released by cytotoxic lymphooytes] -- [spontaneous ~lCr released]) 
([51Cr released  by freeze-thawed  target cells]  --  [spontaneous  51Cr released]) ' 
The standard error of the mean of released radioactivity in triplicate samples rarely exceeded 
5%. Spontaneous release from P815 and EL4 tumor cells after 6 h was approximately 10-15% 
of that released in the freeze-thawed control. The maximum amount of releasable 51Cr, deter- 
mined by freezing and thawing target cells three times, was 90-95% of the total radioactivity 
incorporated into the cells.  Chromium release was immunospecific and occurred only  when 
in  vitro sensitization was directed  against antigens present on  the  respective  target  cells. 
Spleen cells cultured without alloantigens failed to cause a  release of  label greater than the 
spontaneous 51Cr release when assayed with either syngeneic or allogeneic target cells. 
Activation of Spleen Cells with Con A.--50 X  106 spleen cells in 5-ml culture  medium  were 
incubated with or without 2 /zg/ml Con A for 48 h. Cells from  Con A-activated or control 
cultures were harvested, washed twice in HBSS, and resuspended in  fresh culture medium at 
the desired cell density. Graded numbers of cells were added to the MLC in a vol of 0.1 ml. 
Treatment of Spleen Cells with Anti-O Serum and Complement.--Normal  or Con  A-activated 
spleen cells were treated with AKR anti-0 C3H serum and guinea pig serum as a complement 
source to specifically kill T  cells; as a  control, spleen cells were treated with brain-absorbed 
anti-0 serum as described in detail previously (13).  Mter treatment, graded numbers of cells 
were added to the MLC in 0.1-ml vol. 
Cell Irradiation.--Normal  or Con A-activated spleen cells received 2,000 R  of X  irradia- 
tion from a  General Electric Maximar 250 Type III X-ray therapy unit  (General Electric, 
Medical Systems Div.,  General Electric Co., Milwaukee, Wis.)  (10).  After irradiation, cells 
were washed once with HBSS, resuspended in fresh culture medium at the desired cell density, 
and added to the MLC in 0.1-ml vol. 
RESULTS 
Effects of Soluble Con A  on the Generation of Cytotoxic Lymphocytes In  Vitro.- 
The effects of Con A  on the generation of CL was examined by adding varying 
concentrations  of  soluble  Con  A  to  the  MLC  at  initiation.  Spleen  cells  from 
C57BL/6  mice  were  incubated  5  days  with  mitomycin  C-treated  DBA/2 
spleen  cells,  and  the  CL  response  was  measured  by lysis of  51Cr-labeled  P815 
mastocytoma  cells. At submitogenic concentrations (0.05-0.1/zg/ml)  of Con A, 
neither  enhancement  nor suppression  of  CL  responses  was  observed  (Fig.  1). 
Cells  from  these  cultures  had  approximately  the  same  cytotoxic  activity  as 
cells from  control  cultures;  50%  lysis was observed  at lymphocyte/target  cell 
ratios  of  5:1-7:1.  In  contrast,  marked  suppression  of  cytotoxic  activity  was 
observed with mitogenic concentrations (1-5  ~g/ml)  of Con A.  With submito- DUANE  L. PEAVY AND  CARL W. PIERCE  359 
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Fro.  1.  Effects of soluble Con A on the generation of cytotoxic lymphocytes in vitro. MLC 
of C57BL/6 and mitomycin C-treated DBA/2 spleen cells were incubated with the indicated 
concentrations of Con A. Percent specific lysis of 51Cr-labeled P815 mastocytoma target cells 
was determined on day 5. 
genic concentrations  of  Con  A,  total  cell  recovery and  viability were  com- 
parable  in  control  and  Con  A-treated  cultures.  Mitogenic  concentrations of 
Con A, however, substantially increased the numbers of total and viable cells 
per culture. Higher Con A  concentrations (25 ~g/ml), which led to complete 
suppression of CL responses, decreased viable cell recovery to such an extent 
that firm interpretation of the data was prevented. 
The  suppressive  effects of  Con  A  were  not  unique  to  spleen  cells  from 
C57BL/6 mice which are relatively poor responders to Con A as determined by 
[3H]thymidine incorporation (14).  In  experiments employing the same strain 
combinations in reversed roles, DBA/2 spleen cells were incubated with mito- 
mycin C-treated  C57BL/6 spleen  cells and assayed on day 5  with  EL4 leu- 
kemia target cells.  Analogous results were obtained over the range of concen- 
trations of Con A tested. 
Effects of Con A  Added after Culture Initiation  on the Generation of Cytotoxic 
Lymphocytes.--Enhancement  or  suppression  of  PFC  responses  mediated  by 
Con A is dependent on the time Con A was added to the culture (11). Although 
profoundly inhibitory for  PFC  responses  when  added  at  culture  initiation, 
mitogenic  concentrations  of  Con  A  enhanced  PFC  responses  fivefold when 
added  to  cultures at 48 h.  We have performed analogous experiments. 2 #g 
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response  was  assayed  on  day 5.  Soluble  Con A  was  clearly  inhibitory  when 
added  at  culture  initiation  (Fig.  2).  Whereas  significant  suppression  of  CL 
responses was still obtained by adding Con A  24 h  after culture initiation,  the 
ability of Con A  to inhibit 5-day responses was lost after 48 h.  In contrast  to 
the  enhancement  of  PFC  responses  by  mitogenic  concentrations  of  Con  A 
added at 48 h, no increase in the CL response was observed under these condi- 
tions. 
Effects of Con A-activated  Spleen Cells on the Generation of Cytotoxic Lympho- 
cytes In  Vitro.--The  suppression  of CL responses  in  MLC  by mitogenic con- 
centrations  of soluble Con A  could be induced either by: (a)  the activation of 
a  suppressor  cell population;  or  (b)  the  diversion  of alloantigen-sensitive  pre- 
cursor cells into blastogenesis and mitoses which does not result in the genera- 
tion of CL. Experiments were designed to investigate whether Con A  activates 
a  population  of spleen  cells  which  could suppress  generation  of CL  responses 
in vitro.  C57BL/6 spleen cells were incubated with or without 2 #g Con A/ml 
for 48  h  and  graded numbers of viable  control or Con A-activated cells were 
added at initiation  to MLC of C57BL/6 and mitomycin C-treated DBA  spleen 
cells. CL responses were measured 5 days later. When as few as  106 Con A-acti- 
vated  spleen  cells  were  added  to  the  MLC  containing  25  X  106  responding 
C57BL/6  spleen  cells,  CL  responses  were  significantly  diminished  (Fig.  3). 
Moreover,  the  addition  of increasing numbers of Con A-activated cells  (up  to 
2.5  X  106  cells)  resulted  in  increased  inhibition  of  the  CL  responses.  When 
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FIG. 2.  Effects of adding soluble Con A at intervals  after  culture initiation  on cytotoxic 
responses in  vitro.  2 #g Con A/ml were added  to the  MLC of C57BL/6  and  mitomyein 
C-treated  DBA/2 spleen cells at initiation  or 24, 48, and 72 h thereafter.  6]Cr-release assays 
were performed on day 5 using P815 mastocytoma as target cells. DUANE  L.  PEAVY  AND  CARL  W.  PIERCE  361 
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FIG. 3.  Suppression  of  cytotoxic  responses in  MLC  by  Con  A-activated  spleen cells. 
Graded numbers  of viable control  or Con A-activated  cells or an equal volume of culture 
medium were added  to MLC of C57BL/6  and mitomycin C-treated  DBA/2 spleen cells at 
initiation.  Cytotoxic responses were assayed 5 days later on SlCr-labeled P815 mastocytoma 
target cells. 
normal control cells were added,  however,  the cytotoxic activity generated in 
the  MLC  was unaffected.  Percent  viability  and  total  cell  recovery in  all  cul- 
tures  were  comparable.  Analogous results  were  obtained  in  MLC  employing 
Balb/c  suppressor  and  responding  cells  and  mitomycin  C-treated  C57BL/6 
spleen cells where cytotoxic activity was assayed on EL4 target cells. 
The  suppressive  effect  of  Con  A-activated  spleen  cells  on  CL  responses 
assayed  after  5  days incubation  was most pronounced  when  suppressor  cells 
were added at culture initiation.  Addition after 24 h  resulted in approximately 
50 To less inhibition,  while no reproducibly significant suppression was observed 
when  suppressor  cells  were  added  at  48  h  or later.  No  enhancement  of  CL 
responses was noted under any of the conditions employed. However; since all 
cultures  were assayed after 5  days incubation,  suppressor  cells  added  at 48 h 
or later were able  to influence the MLC for only up to 72 h, which may have 
been  too brief a  period  to achieve suppression  by 5  days.  These  experiments 
were expanded and CL responses were measured on days 5  and  7,  times when 
suppressor cells had been present for at least 5 days. The addition of 2.5  X  106 
Con A-activated  C57BL/6  spleen  cells  to  MLC  of C57BL/6  and  mitomycin 
C-treated  Balb/c  spleen  cells  at  initiation  inhibited  both 5  and  7 day CL re- 
sponses  (Figures 4  a  and 4 b).  However, when the suppressor cells were added 
48 h  after initiation  of the MLC, neither 5 nor 7 day CL responses were sup- 
pressed.  The  addition  of 2.5  X  106 control spleen  cells  to the  MLC  at  initia- 362  SUPPRESSION OF  ALLOGRAFT RESPONSES IN  VITRO 
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FIG. 4. Effects of Con A-activated spleen cells on cytotoxic lymphocyte responses assayed 
5 and 7 days after culture initiation. 2.5 X  l0  t viable control or Con A-activated C57BL/6 
spleen cells were added to MLC of C57BL/6 and mitomycin C-treated Balb/c spleen cells at 
initiation or 48 h later. Responses were measured 5 days (Fig. 4 a) and 7 days (Fig. 4 b) after 
culture initiation on 51Cr-labeled P815 mastocytoma target cells. 
tion  or 48  h  thereafter had  no  effect on  5  or 7  day  CL  responses.  Thus,  the 
failure of suppressor cells to inhibit CL responses when added to the MLC  at 
48  h  was  not  due  to  insufficient time for  these  cells to  mediate  their  effects. 
Instead,  suppression  of CL  responses  requires  that  suppressor cells be  added 
during the critical early induction phase of the CL response. 
Kinetics  of CL Responses  in  MLC Containing  Con  A-Activated  Suppressor 
Cells.--The  suppression  of cytotoxic responses  in  MLC  by  Con  A-activated 
suppressor cells could be due  to:  (a)  a  failure to initiate development of CL; 
(b)  partial diminution of CL  development due  to  limited clonal expansion or 
terminal differentiation of activated precursors of CL;  (c)  the abrogation of a 
CL response which initially developed normally; or (d) a delay in development 
of CL which would eventually reach normal levels. Kinetic studies were under- 
taken  to  determine  which  of  these  alternatives  were  valid.  Control  or  Con 
A-activated Balb/c  spleen  cells were  added  at  initiation  to  MLC  of  Balb/c 
and  mitomycin  C-treated  C57BL/6  spleen  cells;  cytotoxic  responses  against 
EL4  target  cells were  measured  on  days 3,  4,  5,  and  6.  By  day 3  weak  but 
detectable CL responses had developed; no measurable differences were found 
between  control  cultures  and  cultures  to  which  Con  A-activated suppressor 
cells had been  added (Fig. 5  a). On days 4,  5,  and 6,  CL responses in control 
MLC  increased progressively (Fig. 5  b-d). However,  during this time, a  defi- 
nite and continued inhibition of CL responses occurred in cultures containing DUANE L.  PEAVY AND  CARL W.  PIERCE  363 
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FIG. 5.  Kinetics of cytotoxic lymphocyte responses in MLC containing Con A-activated 
spleen cells. 2.5 X  106 viable control or Con A-activated Balb/c spleen cells were added to 
MLC of Balb/c and mitomycin C-treated C57BL/6 spleen cells at initiation and cytotoxic 
responses were measured 3 (Fig. 5 a), 4 (Fig. 5 b), 5 (Fig. 5 c), and 6 (Fig. 5 d) days later on 
51Cr-labeled EL4 leukemia target cells. 
suppressor cells. Viable cell recoveries from control and experimental cultures 
declined at comparable rates. These data indicate that  the suppression is the 
result of an abrogative effect of suppressor cells on CL responses which initially 
develop normally during  the  first 3-4  days  of culture,  but  subsequently  ab- 
ruptly abort and decrease precipitously from day 4  to 6. 
Characterization of Con A-Activated Suppressor Cells.--The effect of X  irradi- 
ation and treatment with anti-0 serum and complement to kill T  cells on  the 
generation  and  functional  activity  of  Con-A activated  suppressor  cells  was 
investigated. Portions of Balb/c spleen cells were treated before or after  acti- 
vation with 2/~g Con A/ml for 48 h  as follows: (a)  anti-0 serum and comple- 364  SUPPRESSION  OF  ALLOGRAFT RESPONSES  IN  VITRO 
ment; (b)  brain-absorbed anti-# serum and complement; (c)  2,000  R  X  irradi- 
ation;  and  (d)  untreated.  Con A-activated cells  (2.5  X  106) recovered after 
these treatments were added to the MLC of Balb/c and mitomycin C-treated 
C57BL/6 spleen cells at initiation.  Cytotoxic activity against EL4 target cells 
was measured 5 days later.  Untreated Con A-activated spleen cells  markedly 
suppressed CL responses (Table I). Treatment of spleen cells with anti-# serum 
and complement to kill T  cells before or after activation with Con A abolished 
the suppressive capacity of the cells.  The control of spleen cells  treated  with 
brain-absorbed anti-O serum and complement showed that these manipulations 
did not diminish the suppressive capacity of Con A-activated suppressor cells. 
These results clearly demonstrate that suppressor cells are T  cells. In addition, 
suppressor  T-cell activity as  abolished by  X  irradiation of spleen cells before 
activation  with  Con A.  However,  when  spleen  cells  were  X  irradiated  after 
Con A activation, suppression of CL responses was comparable to that achieved 
with unirradiated Con A-activated cells. 
DISCUSSION 
The results  of these  experiments  clearly indicate  that  Con A  can substan- 
tially inhibit the generation of cytotoxic lymphocytes in vitro. Suppression of 
CL  responses  was  achieved  by  the  addition  of  mitogenic  concentrations  of 
soluble Con A or spleen cells  activated by mitogenic concentrations of Con A. 
The suppression was critically dependent upon the concentration and time of 
addition of Con A or Con A-activated spleen cells. Suppression of CL responses 
under  these  experimental  conditions was  equally  apparent  using spleen  cells 
from C57BL/6, DBA/2, and t3alb/c mice as the responder  cells  in  the MLC 
or as Con A-activated cells.  In part,  these results are  similar to those of Perl- 
TABLE I 
Effect of X  Irradiation and  Anti-O  Serum and Complement 
on Con A-Activated Suppressor Cell Activity 
Time of treatment 
Treatment  relative to Con A-  % Specific lysis  20:1 
activation  Lymphocyte/Target  Cell* 
Normal spleen cell control 
Con A-activated spleen cell control 
Anti-0 and C 
Brain-absorbed anti-0 and C 
X irradiation, 2;000 R 
--  85 
--  37 
Before  82 
After  80 
Before  45 
After  38 
Before  80 
After  37 
* 2.5 X 10  s control or Con A-activated Balb/c spleen cells were added to MLC of 25 X 106 
Balb/c and 25 X  106 mitomycin C-treated C57BL/6 spleen cells at initiation.  51Cr-release 
assays were performed on day 5 using EL4 leukemia as target cells. DUANE  L.  PEAVY  AND  CARL  W.  PIERCE  365 
mann et al.  (15),  who observed that  treatment  of phytohemagglutinin-stimu- 
lated  human  lymphocyte  cultures  with  Con  A  stimulated  incorporation  of 
tritiated  thymidine,  increased  viable  cell  recovery,  but  abrogated  cytotoxic 
responses to chicken erythrocytes. 
Under  appropriate conditions,  lymphocytes previously incubated  with  Con 
A  nonspecifically lyse  target  cells  (16,  17).  Since cytotoxicity is a function of 
viable cells (8), it is possible to argue that the inhibitory effects described here 
may  be  mediated  by  direct  cytotoxicity  of  Con  A-activated  cells  upon  the 
responding  effector cell  population(s).  Suppression  of  CL  responses  was  not 
due  to  direct  cytotoxicity or  the  elaboration  of  toxic  substances  for  several 
reasons:  (a)  in  a  parallel  study,  Con  A,  itself,  in  the  concentrations  used  in 
these experiments failed  to confer cytotoxic activity to spleen cells for either 
syngeneic or allogeneic tumor cells;  2 (b)  addition  of mitogenic concentrations 
of  soluble  Con  A,  which  suppressed  CL  responses,  increased  the  viable  cell 
recovery; (c)  the  75-90%  suppression of CL responses caused by Con A-acti- 
vated spleen cells was not associated with a  corresponding reduction in viable 
cell recovery; (d) suppression of CL responses was not due to interference with 
the lytic process in the assay since addition of Con A or Con A-activated cells 
to  the  51Cr-release  assay did  not  alter  the  result;  2 and  (e)  addition  of either 
Con A  or  Con A-activated spleen cells to  MLC  48 h  or more after initiation 
had no effect on the generation of CL. 
The population  in  Con A-actix~ed spleen cells which mediates suppression 
of  CL  responses  in  MLC  was:ctiaracterized.  The  data  clearly  indicate  that 
suppressive effects were mediaied by T  cells,  since suppressor cell activity was 
abrogated  by  treatment  of  spleen  cells  with  anti-0  serum  and  complement 
before or after activation with  Con A.  Furthermore,  generation  of suppressor 
T-cell  activity was sensitive  to  irradiation  before  Con  A  activation,  whereas 
after Con A  activation, suppressor T-cell function was radioresistant.  In these 
regards,  suppressor  T  cells  are  similar  to  helper  T  cells  known  to  regulate 
B-cell responses to complex multideterminant antigens (1). 
Rich  and  Pierce  (10),  as  well  as Dutton  (18),  have described  inhibition of 
PFC responses by Con A-activated suppressor T  cells.  Although the suppressor 
cells  which  influence  the  humoral  and  cell-mediated  immune  responses  are 
sensitive  to  treatment  with  anti-0  serum  and  complement  and  resistant  to 
irradiation  after activation,  they may represent different populations of regu- 
latory T  cells.  Differences between  the  activities of suppressor T  cells in  the 
two  types  of  immune  responses  are  evident.  First,  PFC  responses  were  in- 
hibited  by suppressor  T  cells added  after 48-h  incubation  (10),  whereas  CL 
responses were inhibited only when suppressor cells were added at MLC initia- 
tion.  Second,  the degree of suppression induced by Con A-activated cells was 
consistently greater on  PFC  responses.  These differences may be due  to  dis- 
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parate  sensitivity  of  the  assays  and  differences  in  the  number  of  initially 
responding  cells,  i.e.,  it  has  been  estimated  that  approximately 1/106  spleen 
cells are  antigenically sensitive to  SRBC  determinants  (19)  while  more  than 
1/102 cells are believed to participate in allograft responses (20). The resolution 
of the question of whether the same or different subpopulations of suppressor 
T  cells regulate PFC and CL responses must await further experimentation. 
Suppression of CL responses required that suppressor cells be present in the 
MLC  during  the  first  24  h  of incubation.  If addition  of suppressor cells was 
delayed 48 h, no inhibition of 5 or 7 day CL responses resulted. Thus, precur- 
sors of CL must be exposed to suppressor cells during the early, yet undefined, 
interactions  among  alloantigens,  and  T  cells  participating  in  CL  responses. 
However, kinetic studies of CL responses in MLC indicated  that suppression 
occurred late in  the  response.  CL responses in MLC  containing  suppressor T 
cells after 3  and 4  days incubation  were similar  to control  responses.  Actual 
suppression  of  these  cultures  manifested  later  as  CL  responses  fell  precipi- 
tously on day 5 and 6. Thus, suppression of CL responses by Con A-activated 
T  cells  cannot  be regarded  as  a  failure  to  initiate  an  immune  response,  but 
represents an abortive attempt. It is possible that activated T  cells may inhibit 
the  clonal  expansion  and  terminal  differentiation  of  alloantigen-sensitive  T 
cells into cytotoxic killer cells.  In this regard,  suppressor cells may behave as 
a homeostatic mechanism limiting the generation of inordinately large numbers 
of cells sensitive to major and minor histocompatibility antigens. It is of great 
interest that the activities of suppressor T  cells in both PFC and CL responses 
are similar. That is,  in both types of responses suppressor T  cells: (a) must be 
present during the early induction phase of the response; (b) do not block ini- 
tiation  of the  response;  but,  (c)  act  to  abort  full  expression  of the  response 
during the later phase of exponential expansion of the effector cells. 
Although both Con A and Con A-activated cells can suppress CL responses, 
it  is  possible  that  suppression  is  mediated  thru  different  mechanisms.  Since 
suppression by Con A-activated cells requires that these cells be present during 
the  first 24  h  of the  MLC, it  seems unlikely  that  there  is  sufficient  time for 
Con A  to activate suppressor cells which  then suppress the CL response. Con 
A may stimulate the alloantigen-reactive T  cells into blastogenesis which does 
not  result in  the generation of CL,  thus  appearing to suppress  this  response. 
Investigations of the mechanisms by which  Con A  and Con A-activated cells 
suppress CL responses are currently in progress. 
The development of in vitro techniques has enabled investigators to deter- 
mine that the generation of CL responses is a complex process involving differ- 
ent  cell  types  (21).  While  ample evidence has  been  offered  that  T  cells  are 
necessary  for  both  afferent  and  efferent  phases  of  cytotoxic  responses,  the 
possibility that  a  cooperative interaction  occurs among subsets  of T  cells in 
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Recent data from several laboratories (22,  23)  have shown that synergy results 
from interactions among thymocytes and peripheral T cells in cellular immunity 
to transplantation antigens. Our observations are consistent with this emerging 
concept of T-cell-T-cell interaction in cellular immune responses  in  the  sense 
that they demonstrate that T lymphocytes may also exert a regulatory influence 
and suppress CL responses. 
SUMMARY 
The  effects of soluble  concanavalin A  (Con  A)  or  Con A-activated spleen 
cells on the generation of cytotoxic lymphocytes (CL) in mixed leukocyte cul- 
tures  (MLC)  were  examined.  Mitogenic  concentrations  of soluble  Con  A  or 
small  numbers  of  Con  A-activated  spleen  cells  substantially  inhibited  CL 
responses. The suppression was partial rather than absolute and was critically 
dependent  upon  the  concentration  and  time of addition  of soluble  Con A  or 
Con A-activated spleen cells to the MLC. 
Suppressive effects of Con-A activated spleen cells were mediated by T  cells 
since suppressor cell activity was abrogated by treatment of spleen cells with 
anti-0 serum and complement before or after Con A  activation. X  irradiation 
of spleen cells before Con A treatment also abrogated generation of suppressor 
cell activity. After activation by Con A, however, the function  of suppressor 
cells was radioresistant. 
Although  the precise mechanism(s)  of suppression is,  as yet, unknown,  the 
precursors of CL must be exposed to  Con A-activated cells during  the early 
phases of the  immune  response for suppression  to  occur.  Kinetic  studies  re- 
vealed that suppression of CL responses was not due to a failure to initiate an 
immune  response,  but  represented  a  response which  developed  initially,  but 
subsequently aborted. The relevance of these observations to the concepts of 
T-cell-T-cell  interaction  and  regulatory  control  of  immune  responses  by  T 
cells is discussed. 
It is a pleasure to thank Professor Baruj Benacerraf for his advice and assistance during 
the progress of these experiments and in the preparation of the manuscript. 
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